Healthcare provider profile · identity verified

Scott A Nitzel, MD

Pediatric Medicine · OLATHE, KS · NPI 1861443749

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	557	155
Levothyroxine Sodium	Levothyroxine Sodium	391	94
Amlodipine Besylate	Amlodipine Besylate	345	96
Pantoprazole Sodium	Pantoprazole Sodium	316	87
Rosuvastatin Calcium	Rosuvastatin Calcium	254	70
Lisinopril	Lisinopril	241	64
Tamsulosin Hcl	Tamsulosin Hcl	220	61
Gabapentin	Gabapentin	204	54
Losartan Potassium	Losartan Potassium	204	60
Metoprolol Succinate	Metoprolol Succinate	179	53
Tramadol Hcl	Tramadol Hcl	178	37
Carvedilol	Carvedilol	167	44
Metformin Hcl	Metformin Hcl	152	42
Potassium Chloride	Potassium Chloride	138	31
Ozempic	Semaglutide	128	18
Trazodone Hcl	Trazodone Hcl	120	35
Famotidine	Famotidine	117	36
Glimepiride	Glimepiride	117	29
Pravastatin Sodium	Pravastatin Sodium	117	28
Sertraline Hcl	Sertraline Hcl	114	32
Fluticasone Propionate	Fluticasone Propionate	112	35
Allopurinol	Allopurinol	110	29
Omeprazole	Omeprazole	108	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	107	28
Warfarin Sodium	Warfarin Sodium	105	15
Hydrochlorothiazide	Hydrochlorothiazide	104	27
Furosemide	Furosemide	100	33
Montelukast Sodium	Montelukast Sodium	94	28
Metformin Hcl Er	Metformin Hcl	90	27
Meloxicam	Meloxicam	86	19
Jardiance	Empagliflozin	83	15
Escitalopram Oxalate	Escitalopram Oxalate	82	22
Farxiga	Dapagliflozin Propanediol	81	15
Pregabalin	Pregabalin	75	15
Alprazolam	Alprazolam	74	28
Eliquis	Apixaban	74	14
Duloxetine Hcl	Duloxetine Hcl	72	17
Clopidogrel	Clopidogrel Bisulfate	67	17
Finasteride	Finasteride	64	19
Ezetimibe	Ezetimibe	63	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	22
Bisoprolol Fumarate	Bisoprolol Fumarate	55	16
Celecoxib	Celecoxib	54	15
Doxazosin Mesylate	Doxazosin Mesylate	54	18
Pioglitazone Hcl	Pioglitazone Hcl	54	14
Alendronate Sodium	Alendronate Sodium	51	19
Albuterol Sulfate Hfa	Albuterol Sulfate	50	26
Olmesartan Medoxomil	Olmesartan Medoxomil	50	13
Clonazepam	Clonazepam	49	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	suppressed
Donepezil Hcl	Donepezil Hcl	44	11
Tizanidine Hcl	Tizanidine Hcl	42	15
Bupropion Xl	Bupropion Hcl	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	37	suppressed
Simvastatin	Simvastatin	37	suppressed
Cephalexin	Cephalexin	36	20
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	11
Zolpidem Tartrate	Zolpidem Tartrate	30	12
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	29	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Irbesartan	Irbesartan	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	11
Valacyclovir	Valacyclovir Hcl	24	suppressed
Glipizide	Glipizide	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Amoxicillin	Amoxicillin	22	13
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Colestipol Hcl	Colestipol Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Topiramate	Topiramate	20	suppressed
Atenolol	Atenolol	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Nystatin	Nystatin	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Invokana	Canagliflozin	16	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	16	suppressed
Prednisone	Prednisone	16	14
Acyclovir	Acyclovir	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Temazepam	Temazepam	14	suppressed
Testosterone	Testosterone	14	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Ropinirole Er	Ropinirole Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Glipizide Er	Glipizide	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error